ARTICLE | Company News
Genvax Ltd., Medical Marketing deal
September 6, 2004 7:00 AM UTC
MMG spun out Genvax, which will develop a technology that involves fusing portions of tetanus toxin with cancer proteins in order to stimulate an immune response. Genvax has three DNA-based vaccines i...